Results 181 to 190 of about 4,746,761 (313)

An optimized protocol to detect high‐throughput DNA methylation from custom targeted sequences on 96 samples simultaneously

FEBS Open Bio, EarlyView.
Workflow of a high‐throughput technology for epigenotyping of differentially methylated CpGs in specific regions of the genome. The protocol works with small amounts of DNA extracted from blood or semen. The protocol consists of both enzymatic conversion of unmethylated cytosines and capture by hybridization with a custom panel.
Nathalie Iannuccelli, Sophie Valière, Julien Sarry, Cécile Donnadieu, Julie Demars   +4 more
wiley   +1 more source

"It's nothing personal": understanding barriers to relational harm reduction practices during inpatient hospitalization. [PDF]

Harm Reduct J
Leon K, Weger R, Weinstock N, Jawa R, Wilson JD.   +4 more
europepmc   +1 more source

Smoke from traditional commercial, harm reduction and research brand cigarettes impairs oviductal functioning in hamsters (Mesocricetus auratus) in vitro

, 2006
Michael Iv, Vu Long Tran, Ryan Roza, Denise Kwan, Prue Talbot   +4 more
openalex   +1 more source

Henceforth harm reduction? [PDF]

International Journal of Drug Policy, 2012
openaire   +3 more sources

Downregulation of sST2, a decoy receptor for interleukin‐33, enhances subcutaneous tumor growth in murine pancreatic cancer cells

FEBS Open Bio, EarlyView.
Subcutaneous implantation of murine Panc02 pancreatic cancer cells depleted of sST2, a soluble decoy receptor for the proinflammatory interleukin‐33 (IL‐33), leads to a decreased number of GLUT4‐positive cancer‐associated adipocytes, reduced levels of the anti‐inflammatory molecule adiponectin, increased phosphorylation of IκBα, elevated Cxcl3 ...
Miho Akimoto, Nobuko Koshikawa, Takao Morinaga, Mimi Tamamori‐Adachi, Atsushi Takatori, Keizo Takenaga   +5 more
wiley   +1 more source

Vernacular and discursive harm reduction: an ethnography of an online drug community. [PDF]

Harm Reduct J
Gilles S.
europepmc   +1 more source

The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US [PDF]

, 2009
Mitchell Zeller, Dorothy K. Hatsukami
openalex   +1 more source

Cis‐unsaturated sphingolipids support growth of sphingoid base‐deficient yeast but impair plasma membrane integrity

FEBS Open Bio, EarlyView.
Sphingoid base structures, the sphingolipid backbones, vary among species. We established yeast cells in which the native sphingoid base was replaced with plant‐type bases containing cis or trans double bonds. This is, to our knowledge, the first eukaryotic model mostly composed of sphingolipids containing cis‐unsaturated sphingoid base, providing a ...
Takashi Higuchi, Saki Sugihara, Yohei Ishibashi, Kono Yushi, Hazuki Yamauchi, Motohiro Tani   +5 more
wiley   +1 more source

Commentary on Harding et al.: Responding to ketamine use disorder-Integrating practice, research, and whole-system approaches to harm reduction. [PDF]

Addiction
Ralphs R, Day J, Dewhurst J.
europepmc   +1 more source

Public Health Implications of Smokeless Tobacco Use as a Harm Reduction Strategy

, 2006
David A. Savitz, Roger E. Meyer, J.M. Tanzer, Sidney S. Mirvish, Freddi Lewin   +4 more
openalex   +2 more sources